On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its ...

Qure advances its pathology-shifting AMT-130 therapy for Huntington's disease; pivotal data and commercial launch prep target 2025 milestones.

In the ever shifting theatre of global militancy, women are no longer just sitting in the wings, but have, unfortunately, ...

Sette added that like rodents, cockroaches produce important allergens, particularly in under-resourced urban settings.

Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.

As insurgents escalate their offensive against Pakistani forces in Balochistan, Munir’s rhetoric looks increasingly like a ...

As Baloch insurgents escalate deadly attacks on Pakistani forces and inflict casualties, Army Chief Asim Munir has blamed India for intensifying the unrest in the restive province. Munir said India's ...

The FDA has accepted for priority review the resubmitted BLA for tabelecleucel to treat patients 2 years of age and older with EBV+ PTLD who have received at least 1 prior therapy.

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that ...

Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor ...

The FDA’s top vaccine and gene therapy official resigned amid heightened scrutiny over recent drug approval decisions and ...

Bihar Chief Minister Nitish Kumar has announced a significant hike in the honorarium for ASHA and Mamta workers in ...